Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.39 | 3e-13 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.31 | 6e-12 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-08 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-08 |
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-08 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.2 | 4e-07 |